(Q85025638)

English

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

scientific article published on September 14, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Circulating fibroblast growth factor-23 increases following intermittent parathyroid hormone (1-34) in postmenopausal osteoporosis: association with biomarker of bone formation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation (English)

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

1 reference

based on heuristic

inferred from title

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

M. Sridharan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

J. Cheung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

A. E. Moore

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

M. L. Frost

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

W. D. Fraser

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

I. Fogelman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

G. Hampson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838781

12 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20838781

12 July 2024

publication date

14 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00223-010-9414-8.pdf

Portable Document Format

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

http://link.springer.com/article/10.1007/s00223-010-9414-8/fulltext.html

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

http://link.springer.com/content/pdf/10.1007/s00223-010-9414-8

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Calcified Tissue International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

87

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

398-405

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20838781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

https://scigraph.springernature.com/pub.10.1007/s00223-010-9414-8

0 references

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

2

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Novel regulators of phosphate homeostasis and bone metabolism

3

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

4

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells

5

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

6

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

7

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

8

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

9

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

10

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism

11

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.

12

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

13

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients

14

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

15

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Regulation of fibroblast growth factor 23 production in bone in uremic rats.

16

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

17

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men.

19

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Mineralized tissue cells are a principal source of FGF23.

20

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro

21

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Genetic evidence of serum phosphate-independent functions of FGF-23 on bone

22

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

23

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

24

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

25

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

SOST is a target gene for PTH in bone

26

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis

27

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Control of bone mass and remodeling by PTH receptor signaling in osteocytes

28

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

UK Consensus Conference on Early Chronic Kidney Disease--6 and 7 February 2007

29

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis

30

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis

31

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate

32

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

33

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.

34

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

35

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays.

36

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.

37

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

38

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia

40

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Clinical science and molecular medicine

41

49

45

author name string

RJ Walton

publication date

1975

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates

42

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)

43

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Bone formation regulates circulating concentrations of fibroblast growth factor 23.

44

1 reference

10.1007/S00223-010-9414-8

https://api.crossref.org/works/10.1007/S00223-010-9414-8

12 July 2024

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85025638&oldid=2202372866"